Testing how motilin affects appetite and food intake frequency
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether motilin changes how often and how much people eat. It likely helps researchers understand appetite control, which can be relevant for weight and digestive health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to understand the study and sign consent
- Your body mass index (BMI) must be either under 30 or over 30
- If you could become pregnant, you must use hormonal birth control (pill, injection, or implant)
- You cannot be pregnant or breastfeeding
- You should not have major stomach or intestinal diseases or major past belly surgery
- You must not use medicines that affect the gut or the brain (central nervous system)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug (NNC0487-0111) to see how it changes food intake, appetite, and the way your body processes food after meals. It is for adults with obesity who do not have diabetes.
This study tests whether taking probiotics can help regulate appetite in people who are overweight or have obesity. It aims to understand if these supplements can support weight management by affecting hunger and fullness signals.
This study tests whether motivational interviewing can help overweight or obese adults lose weight and improve eating habits. It looks at changes in body measurements and a heart health score.
This study uses an MRI brain scan to understand why you feel hungry, satisfied, or “pulled” to eat, and how your body’s internal balance affects food intake. It may help researchers learn more about eating regulation, which could guide future treatments.
This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.
This study tests an investigational medication called MBX 4291 for adults with obesity. It aims to see if the drug is safe and how it works in the body, which could lead to a new weight-loss treatment option.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.